Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
723. World Health Organization.<br />
Rec 2001; 76: 33-9.<br />
BCG in immunization programmes. Wkly Epidem<br />
724. Close GC, Nasiiro R. Management of BCG adenitis in infancy.<br />
(Correspondence). J Trop Pediatr 1985; 31: 286.<br />
725. Hanley SP, Gumb J, Macfarlane JT. Comparison of erythromycin <strong>and</strong> isoniazid<br />
in treatment of adverse reactions to BCG vaccination. BMJ 1985; 290: 970.<br />
726. Oguz F, Müjgan S, Alper G, Alev F, Neyzi O. Treatment of Bacille Calmette-<br />
Guérin-associated lymphadenitis. Pediatr Infect Dis J 1992; 11: 887-8.<br />
727. Victoria MS, Shah BR. Bacillus Calmette-Guérin lymphadenitis: a case report<br />
<strong>and</strong> review of the literature. Pediatr Infect Dis 1985; 4: 295-6.<br />
728. Banani SA, Alborzi A. Needle aspiration <strong>for</strong> suppurative post-BCG adenitis.<br />
Arch Dis Child 1994; 71: 446-7.<br />
729. Boman G, Sjögren I, Dahlström G. A follow-up study of BCG-induced osteoarticular<br />
lesions in children. Bull Int Union Tuberc Lung Dis 1984; 59: 198-200.<br />
730. Last JM. A dictionary of epidemiology. 3 ed. New York: Ox<strong>for</strong>d University<br />
Press, 1995; pp. 1-180.<br />
731. Rothman KJ, Greenl<strong>and</strong> S. Modern epidemiology. 2 ed. Philadelphia:<br />
Lippincott - Raven Publishers, 1998; pp. 1-738.<br />
732. Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ,<br />
Sirotkin B. Field evaluation of vaccine efficacy. Bull World Health Organ 1985;<br />
63: 1055-68.<br />
733. Smith PG. Retrospective assessment of the effectiveness of BCG vaccination<br />
against tuberculosis using the case-control method. Tubercle 1982; 63: 23-35.<br />
734. Schlesselman JJ. Case-control studies. Design, conduct, analysis. 1 ed. New<br />
York: Ox<strong>for</strong>d University Press, 1982; pp. 1-354.<br />
735. Rodrigues LC, Smith PG. Use of the case-control approach in vaccine evaluation:<br />
efficacy <strong>and</strong> adverse effects. Epidemiol Rev 1999; 21: 56-72.<br />
736. Aronson JD, Dannenberg AM. Effect of vaccination with BCG on tuberculosis<br />
in infancy <strong>and</strong> in childhood. Correlation of reactions to tuberculin tests, roentgenologic<br />
diagnosis <strong>and</strong> mortality. Am J Dis Child 1935; 50: 1117-30.<br />
737. Feldberg GD. Disease <strong>and</strong> class. <strong>Tuberculosis</strong> <strong>and</strong> the shaping of modern North<br />
American society. 1 ed. New Jersey: Rutgers University Press, 1995; pp. 1-214.<br />
738. Aronson JD, Palmer CE. BCG vaccination among American Indians. Publ<br />
Health Rep 1946; 61: 802-20.<br />
739. Townsend JG, Aronson JD, Saylor R, Parr I. <strong>Tuberculosis</strong> control among the<br />
North American Indians. Am Rev Tuberc 1942; 45: 41-2.<br />
740. Aronson JD, Aronson CF, Taylor HC. A twenty-year appraisal of BCG vaccination<br />
in the control of tuberculosis. Arch Intern Med 1958; 101: 881-93.<br />
218
Change language